References
- Schwartz RH, Wientzen RL, Pedreira F, Feroli E, MeIla G. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA 1981; 246: 1790–5.
- Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phe-noxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46.
- Roos K, Holm SE, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over the age of ten and in adults. Clinical and therapeutical aspects. Scand J Infect Dis 1985; 17: 357–65.
- Hamburger M, Green MJ, Hamburger VG. The prob-lem of the "dangerous carrier" of haemolytic strepto-cocci. Number of haemolytic streptococci expelled by carriers with positive and negative nose cultures. J Infect Dis 1945; 77: 68–81.
- Crowe CC, Sanders WE Jr, Longley S. Bacterial inter-ference. II. Role of the normal throat flora in preven-tion of colonisation of group A streptococcus. J Infect Dis 1973; 527–32.
- Sanders CC, Sanders WE, Harrowe DJ. Bacterial inter-ference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A strepto-cocci. Infect Immun 1976; 13: 808–12.
- Sanders CC, Nelson GE, Sanders WE. Bacterial inter-ference. IV. Epidemiological determinants of the antag-onistic activity of the normal throat flora against group A streptococci. Infect Immun 1977; 16: 599–603.
- Grahn E, Holm SE, Ekedahl C, Roos K. Interference of alpha-haemolytic streptococci isolated from tonsillar surface of beta-haemolytic streptococci C (Streptococ-cus pyogenes) - a methodological study. Zbl Bact Hyg (A) 1983; 254: 459–68.
- Roos K, Grahn E, Holm SE. Evaluation of beta-lacta-mase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 1986; 18: 313–9.
- Sprunt K, Leidy G, Redman W. Abnormal colonisa-tion of neonates in an ICU: conversion to normal colonisation by pharyngeal implantation of alpha-haemolytic streptococcus strain 215. Pediatr Res 1980; 14: 308–13.
- Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int .1 Pedi-atr Otorhinolaryngol 1993; 25: 141–8.
- Roos K, Holm SE, Grahn E, Lind L. Alpha-strepto-cocci as supplementary treatment of recurrent strepto-coccal tonsillitis: a randomised placebo-controlled study. Scand J Infect Dis 1993; 25: 31–5.
- Roos K, Holm SE, Grahn E, Lagergren L. Recoloniza-tion with four selected alpha-streptococcal strains in the treatment of recurrent streptococcal tonsillitis - a placebo-controlled randomized multicenter study. Scand J Infect Dis 1996; 28: 459–62.
- Griffith F. The serological classification of Streptococ-cus pyogenes. J Hyg 1934; 34: 542–84.
- Maxted WR, Widdowson JP. The protein antigens of group A streptococci. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. New York: Academic Press, 1972: 256–61.
- Gordon JE. Epidemiology of scarlet fever. JAMA 1932; 98: 519–24.
- Holmstrom L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-re-sistant group A streptococci in day care centres. Scand J Infect Dis 1990; 22: 179–85.
- Stromberg A, Schwan A, Cars O. Throat carrier rates of beta-hemolytic streptococci among healthy adults and children. Scand J Infect Dis 1988; 20: 411–7.